TrialLancet (London, England)2002

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Lars H Lindholm et al.PubMed ↗Publisher ↗

No numbers read from the abstract.